Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014

…, HME Duggan, S Gomez, NMB Martin, L Ruston…

Index: Pike, Kurt G.; Malagu, Karine; Hummersone, Marc G.; Menear, Keith A.; Duggan, Heather M.E.; Gomez, Sylvie; Martin, Niall M.B.; Ruston, Linette; Pass, Sarah L.; Pass, Martin Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 5 p. 1212 - 1216

Full Text: HTML

Citation Number: 64

Abstract

The optimization of a potent and highly selective series of dual mTORC1 and mTORC2 inhibitors is described. An initial focus on improving cellular potency whilst maintaining or improving other key parameters, such as aqueous solubility and margins over hERG IC50, led to the discovery of the clinical candidate AZD8055 (14). Further optimization, particularly aimed at reducing the rate of metabolism in human hepatocyte incubations, resulted in the ...